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Sensory axon development requires concerted ac-
tions of growth factors for the precise control of
axonal outgrowth and target innervation. How devel-
oping sensory neurons integrate different cues is
poorly understood. We demonstrate here that
Smad1 activation is required for neurotrophin-medi-
ated sensory axon growth in vitro and in vivo.
Through differential phosphorylation, Smad1 exerts
transcriptional selectivity to regulate the expression
and activity of Erk1 and Erk2—two key neurotrophin
effectors. Specifically, bone morphogenetic proteins
(BMPs) signal through carboxy-terminal phospho-
rylation of Smad1 (pSmad1C) to induce Erk1/2
transcription for enhanced neurotrophin responsive-
ness. Meanwhile, neurotrophin signaling results in
linker phosphorylation of Smad1 (pSmad1L), which
in turn upregulates an Erk-specific dual-specificity
phosphatase, Dusp6, leading to reduced pErk1/2
and constituting a negative-feedback loop for the
prevention of axon overgrowth. Together, the BMP
and neurotrophin pathways form a tightly regulated
signaling network with a balanced ratio of Erk1/2
and pErk1/2 to direct the precise connections be-
tween sensory neurons and peripheral targets.INTRODUCTION
During sensory circuit wiring, embryonic neurons need to inte-
grate various extracellular cues for the precise control of initia-
tion, elongation, and branching of their axons. It remains to be
clarified howmultiple signaling pathways converge to collabora-
tively mediate axon development.
The neurotrophin family plays a central role in stimulating
axonal outgrowth. Nerve growth factor (NGF), a prototypic neu-
rotrophin, is target derived and modulates terminal sensory
axon branching. In NGF knockout mice on a Bax/ background
that prevents neuronal cell death, terminal arborization and
epidermal innervation are impaired (Patel et al., 2000). Neurotro-1592 Cell Reports 3, 1592–1606, May 30, 2013 ª2013 The Authorsphins bind to receptor tyrosine kinases of the Trk family and
signal through well-conserved effectors: mitogen-activated
protein kinase/extracellular signal-regulated kinase (MAPK/Erk)
and phosphatidylinositol-3-kinase/Akt (PI3K/Akt; Reichardt,
2006). In cultured neurons, both pathways are required for
peripheral axon outgrowth, whereas PI3K/Akt is more involved
in cell survival (Atwal et al., 2000; Kaplan and Miller, 2000).
Double deletion of either Braf/Raf1 or Erk1/Erk2 results in aber-
rant terminal branching of sensory axons in the NGF-expressing
target field in vivo (Newbern et al., 2011; Zhong et al., 2007).
Although the critical roles of NGF/TrkA pathways in sensory
axon outgrowth have been amply demonstrated, it is less
clear how the expression and activity of individual signaling
components are regulated to ensure proper neurotrophin
responsiveness in the developing neurons. Furthermore,
safeguard mechanisms to prevent axon overgrowth remain to
be uncovered.
Other growth factors involved in axonal outgrowth include the
bone morphogenetic proteins (BMPs). BMPs, members of the
transforming growth factor b (TGF-b) superfamily, play a variety
of roles in neural development (Liu and Niswander, 2005). BMPs
activate receptor serine/threonine kinases (BMPR) and signal
through C-terminal phosphorylation of Smads (pSmadC; Feng
and Derynck, 2005; Shi and Massague´, 2003). Previously, we
showed that Smad1, one of the Smads that mediate BMP
signaling, is developmentally regulated (Zou et al., 2009).
pSmad1C accumulates in the nuclei of embryonic sensory neu-
rons in the dorsal root ganglia (DRGs) from embryonic day 10.5
(E10.5) to E15.5 during active axonal outgrowth. Blocking BMP
signaling by pharmacological inhibition of its receptors or by
RNA interference (RNAi)-mediated Smad1 knockdown results
in an arrest of axonal outgrowth in cultures (Parikh et al., 2011).
In vivo evidence confirming the role of Smad1 in axonal growth
has yet to be established. Importantly, when adult DRG neurons
are triggered into a regenerative state, Smad1 is induced and
activated, and enhances the regeneration of sensory axons after
spinal cord injury (Parikh et al., 2011).
An intriguing phenomenon observed in previous studies (Par-
ikh et al., 2011) is that when BMP signaling is blocked, axonal
outgrowth is arrested even though neurotrophin is present in
the culture media, suggesting that BMP signaling is required
for neurotrophin-mediated axonal outgrowth. However, the
question remains as to whether the two pathways converge on
a common node or function in parallel with distinct downstream
targets. Precedent exists for a collaboration between BMP and
neurotrophin (for example, BMP7 requires NGF as a cofactor
to optimally induce dendritic growth in sympathetic neurons;
Lein et al., 1995), but mechanistic understanding is lacking.
One possible convergence point is Smads. In addition to
C-terminal phosphorylation sites, Smads also have a linker
area between the MH1 and MH2 domains. This area contains
four conservedMAPKphosphorylation sites that can be targeted
by members of the MAPK family (Erk, p38, and c-Jun N-terminal
kinase [JNK]; Hough et al., 2012; Pera et al., 2003) and several
glycogen synthase kinase (GSK) phosphorylation sites. Integra-
tion of dorsoventral (BMP) and anteroposterior (Wnt/GSK3)
patterning gradients reportedly occurs through differential phos-
phorylation of Smad1 in Xenopus embryos (Fuentealba et al.,
2007). The in vivo function of linker phosphorylation of Smad1
(pSmad1L) in the mammalian nervous system is not known.
Here, we tested the hypothesis that Smad1 functions as a
convergence node of the BMP and neurotrophin pathways
during sensory axon development. We show that Smad1 is
specifically expressed in the developing peripheral sensory
neurons and that it is activated at both its C terminus and linker
region. By studying cultured embryonic DRG neurons and in vivo
axon growth patterns in three Smad1 mutant alleles (two condi-
tional deletions and one linker mutation), we demonstrate that
Smad1 activation is required for NGF-mediated terminal axon
branching. We identify Erk1 and Erk2 as pSmad1C transcrip-
tional targets and reveal a pSmad1L-Dusp-based negative-
feedback loop that regulates the intensity of Erk1/2 signaling,
thus establishing distinct in vivo roles for pSmad1C and
pSmad1L during sensory neuron development. Together, the
molecular events of the BMP and neurotrophin pathways
contribute to a tightly regulated signaling network that directs
the precise connections between sensory neurons and their
targets.
RESULTS
Neurotrophin-Induced Axonal Outgrowth Specifically
Requires BMP Signaling
To investigate how the neurotrophin and BMP pathways collab-
oratively mediate sensory axon development, we isolated
E12.5 DRGs andmonitored axonal outgrowth in explant cultures
in media containing NGF and an increasing concentration of
dorsomorphin (DM), an inhibitor of the type I BMP receptor
that blocks activation of Smad1/5/8 (Yu et al., 2008). Axonal
outgrowth was inhibited by DM treatment in a dose-dependent
manner (Figures 1A and 1B). At higher doses of DM, axonal
outgrowth was completely arrested, confirming the requirement
of BMP signaling for NGF-mediated axonal outgrowth. The
inhibitory effect of DM was reversible, since DRG neurons
resumed growth after DM washout (Figure 1B), indicating no
permanent adverse effect from DM treatment. Similar DM-
mediated inhibition of axonal outgrowth was observed in
dissociated E12.5 DRG neurons plated at low density to mini-
mize the effect of glial cells (Figure 1C).
To examine whether the requirement for NGF-mediated
axonal outgrowth is specific to the BMP branch of the TGF-bCsuperfamily, we treated E12.5 DRG explants with SB431542, a
specific TGF-b signaling inhibitor. No inhibitory effect was
observed (Figures 1A and 1B). Application of a protein kinase
A (PKA) inhibitor also did not affect axonal length (Figure S1A),
as previously reported (Liu and Snider, 2001).
pSmad1C Is Present Specifically in Embryonic DRG
Neurons and Is Required for Neurotrophin-Mediated
Axonal Outgrowth
We next investigated whether it is the canonical BMP pathway
signaling through pSmad1C that is involved in NGF-dependent
axonal outgrowth. The axonal growth arrest with DM treatment
occurs in parallel with a marked reduction of pSmad1C in embry-
onic DRG neurons (Figure 1D), suggesting the involvement of
pSmad1C in axonal outgrowth. To rule out nonspecific effects
of DM and further confirm the requirement of pSmad1C for
NGF-mediated axon growth, we decided to repeat the study
using E12.5 DRGs from mutant mice with a genetic deletion of
Smad1. Because of the early lethality of Smad1/ embryos
(Lechleider et al., 2001), we generated conditional knockout
(cKO) mice (Smad1fl/;Nestin-Cre; hereafter referred to as
Smad1 cKONes). Nestin-Cre induces recombination in neural
progenitor cells and is expected to ablate Smad1 specifically
in DRG sensory neurons as early as E11.5 while sparing
Schwann cells (Dubois et al., 2006; Kao et al., 2009; Tronche
et al., 1999), which we confirmed using the Rosa26-EYFPSTOP
reporter line (Figures S1C–S1E). First, western blotting
confirmed that Smad1 was markedly reduced in E12.5 mutant
DRGs as compared with Smad1fl/+;Nestin-Cre control litter-
mates (Figure 1E). Immunostaining showed that pSmad1C was
abundantly present in the nuclei of 95.6% ± 5.5% of the sensory
neurons inwild-type (WT) DRGs at postnatal day 1 (P1), but not in
Smad1 cKONes DRGs (Figure 1F). Notably, colabeling with
pSmad1C and b-tubulin III (Tuj1), a pan-neuronal marker,
demonstrated that the pSmad1C immunosignals were specif-
ically detected in sensory neurons, but not in satellite glial cells
in DRGs or in developing Schwann cells populating the periph-
eral nerves (Woodhoo et al., 2009; Figures 2A and 2B), thus
supporting a role for Smad1 in the development of sensory
neurons but not Schwann cells. We then compared the axonal
outgrowth of E12.5 DRG explants from Smad1 cKONes and
control littermates in NGF-containing media. Mutant DRGs
with Smad1 deletion grew shorter axons than the WT DRGs,
with average axonal lengths of 346.6 mm ± 29.0 SEM and
431.7 mm ± 16.2 SEM, respectively, after 24 hr in culture (Fig-
ure 1G). We therefore conclude that pSmad1C-mediated BMP
signaling is required for NGF-dependent axonal outgrowth.
Smad1 Deletion Hinders Terminal Branching
of Peripheral Axons
Next, we investigated the in vivo role of pSmad1C in sensory
neuron development by first examining sensory axon projections
in Smad1 cKONes mice. We focused on cutaneous innervation, a
well-characterized NGF-dependent process, in the mystacial
pads of newborn pups by immunostaining for a pan-axonal
marker, protein gene product 9.5 (PGP9.5), and a small-caliber
axon marker, calcitonin gene-related peptide (CGRP). The
Smad1 cKONes newborn pups displayed a mild but significantell Reports 3, 1592–1606, May 30, 2013 ª2013 The Authors 1593
Figure 1. BMP/Smad Signaling Is Required
for NGF-Dependent Axon Growth
(A and B) E12.5 DRG explants were cultured in
NGF-containing media for 48 hr with DM (1 or
5 mM) or SB431542 (5 mM) and axonal length was
determined by Tuj1 immunostaining and averaged
over six independent experiments (n = 6). w.o., DM
washout.
(C and D) Low-density dissociated cultures of
E12.5 DRG neurons were treated with DM (1 mM)
for 48 hr.
(C) Quantification of the average axonal length.
(D) pSmad1C immunostaining. DM treatment
reduced pSmad1C nuclear levels (n = 3).
(E) Western blotting of DRG extracts from E12.5
embryos with antibodies indicated (histone 4 [H4]
served as the loading control).
(F) Immunohistochemistry of P1 DRGs and quan-
tification showed that pSmad1C was present
specifically in WT DRGs but absent in Smad1
cKONes DRGs.
(G) E12.5 DRG explants from Smad1 cKONes or
control embryos were cultured in NGF-containing
media for 48 hr, and axonal lengths were deter-
mined by Tuj1 immunostaining and averaged over
three independent experiments.
Scale bar: 200 mm (A and G), 50 mm (D), and
100 mm (F). Error bars represent SEM. See also
Figure S1.truncated distal network of axons and diminished terminal
arborization in the upper dermis as compared with littermate
controls (Figures 2C and S2). The average number of axonal
branches at the junction of the upper dermis and epidermis
over a similar field examined was 8.8 in control pups and 6.0 in
Smad1 cKONes pups (a 32% decrease; Figure 2D). Similarly,
the number of CGRP+-terminal axonal branches per similar field
examined was reduced from 7.8 in control pups to 6.1 in Smad1
cKONes pups (a significant 22% decrease; Figures 2C and 2D).
It is unlikely that the decrease in terminal axon branches was
due to a reduced expression of PGP9.5 or CGRP in mutant
pups, as their immunoreactivity in sensory neuron soma
appeared comparable and the total numbers of PGP9.5+ or
CGRP+ neurons in P1 DRGs from the same thoracic spinal
segment were also similar regardless of the genotypes (Figures
3D and 3E). Because the terminal axon defects were detected
in P1 mice, they more likely originated from stunted distal axonal1594 Cell Reports 3, 1592–1606, May 30, 2013 ª2013 The Authorsbranching than from axonal retraction.
The phenotypes are reminiscent of
those observed in NGF/;Bax/ or
TrkA/;Bax/ mice, although they are
milder, which may be attributed to com-
pensatory mechanisms from different
Smads or other molecules involved in
sensory axon growth (Patel et al., 2000).
We also examined whether Smad1 is
required for directing central projections
of sensory axons. In Smad1 cKONes P1
pups, the small-caliber CGRP+ nocicep-
tive axons entered the dorsal spinallaminae in a normal pattern, and the large-caliber parvalbumin
(PV)+ proprioceptive afferent axons also projected toward the
ventral motor pools in a normal fashion (Figure 3A). Therefore,
Smad1 appears to be dispensable for central axon projection
in vivo. Taken together, these findings indicate that Smad1
signaling is specifically required for proper NGF-mediated target
innervation of sensory axons.
Smad1 Is Not Required for Neurotrophin-Mediated
Survival and Differentiation of Sensory Neurons
We next asked whether BMP/Smad1 is required for two other
key processes that are neurotrophin dependent: survival and
differentiation of sensory neurons. The survival of TrkA+ DRG
neurons is dependent upon successful competition for target-
derived NGF (White et al., 1996), whereas the survival of TrkC+
neurons depends on NT3 (Wyatt et al., 1999). We first assessed
the extent of cell death in embryonic DRGs by immunostaining
Figure 2. pSmad1C Is Present Specifically in DRG Sensory Neurons and Is Required for Terminal Axon Branching
(A and B) Immunostaining of E16.5 DRGs (A, confocal images) or E15.5 and P1 DRGs and peripheral nerves (B) from WT mice shows that immunosignals of
pSmad1Cwere specifically detected in themajority of neurons,but not in satellite glial cells (A) or indevelopingSchwanncells populating thenerves (Tuj1, green,B).
(C and D) Representative images and quantification of cutaneous innervation of mystacial pads of P1 pups with immunostaining for PGP9.5 (green, arrows, top
panel) or CGRP (green, arrows, bottom panel) and DAPI counterstaining.
(D) The average number of axon terminal branches in the upper dermis per field examined was calculated from five independent 203 images from each pup
and then averaged over five pairs of littermates.
Scale bars: 50 mm (A), 100 mm (B), and 50 mm (C). Error bars represent SEM. See also Figure S2.
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Figure 3. BMP/Smad1 Is Not Required for NGF-Mediated Cell Survival or Differentiation of Peripheral Sensory Neurons
(A) Images of spinal cords of P1 Smad1 cKONes or control pups immunostained for PV or CGRP (red) and counterstained with DAPI (blue).
(B) Apoptotic sensory neurons in E15.5 DRGs were revealed by antibody against activated caspase-3 (a-casp3) and quantified.
(C) E12.5 DRG explants were cultured for 48 hr and immunostained for a-casp3. Quantification was averaged over duplicate DRGs cultures from three littermate
pairs (n = 3, left). Quantification of E12.5 DRG explants cultured for 48 hr with or without DM was shown in graph on the right (n = 6).
(D and E) Sensory neuron differentiation in P1 DRGs was determined by immunostaining for the indicated markers and quantified in randomly selected fields of
similar sizes from thoracic DRGs of the same spinal segments.
Scale bars: 200 mm (A), 50 mm (B, D, and E), and 100 mm (C). Error bars represent SEM. See also Figure S3.
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for activated caspase 3, a marker of apoptosis. Loss of Smad1
did not have an impact on neuronal survival at E15.5, one of
the peak times of apoptosis in developing DRGs (White et al.,
1996; Figure 3B). The numbers of total DRG neurons (Tuj1+ or
PGP9.5+) from the same thoracic spinal segment of P1 mice
were also comparable regardless of the genotypes (Figure 3D).
Additionally, TrkA+ small-diameter neurons and PV+ large-
diameter neurons were similar in number in P1 DRGs (Figure 3E).
To rule out a compensatory mechanism by other Smads,
E12.5 WT DRG explants were cultured with NGF for 2 days
with or without DM treatment, and no change in the percentage
of apoptotic cells in DRG explants was found (Figure 3C).
Similar results were demonstrated in E12.5 DRG explants from
Smad1 cKONes or control embryos after 2 days of culture
(Figure 3C).
We then investigated whether loss of Smad1 might affect
neurotrophin-dependent neuronal differentiation. We did not
detect a difference in the number of TrkA+, CGRP+, or PV+
sensory neurons in P1 thoracic DRGs from mutant or control
pups (Figure 3E). Together, these findings indicate that Smad1
is specifically required for neurotrophin-mediated axonal
outgrowth, but not for the survival or differentiation of sensory
neurons in vivo.
In further support of our conclusion, we confirmed all our find-
ings in another conditional mutant mouse, Smad1fl/+;Wnt1-Cre
(Smad1 cKOWnt1). Wnt1-Cre induces recombination in premi-
gratory pluripotent neural crest cells at approximately E8.5,
and thus is expected to affect both Schwann cells and DRG
sensory neurons (Danielian et al., 1998; Figures S1C–S1E). We
observed no changes in central branch innervation, cell death,
or differentiation of DRG neurons in the Smad1 cKOWnt1 mice
(Figure S3), whereas the average number of terminal axon
branches per field inspected in mystacial pads was significantly
decreased by 43% in Smad1 cKOWnt1 pups as compared with
control littermates (Figures S3B and S3C).
Next, we investigated whether a delay or deficit in the initial
phase of axon outgrowth could explain the aberrant terminal
branching in mutants. Notably, early outgrowth of sensory
axons in vivo is neurotrophin independent (Davies et al., 1987;
O’Connor and Tessier-Lavigne, 1999). We postulated that
BMP might regulate this early process. To test this hypothesis,
we performed whole-mount immunostaining for neurofilament
marker 2H3 on E11.5–E12.5 embryos. Because Nestin-Cre
induces recombination starting from E11.5, we focused on
Smad1 cKOWnt1 to evaluate early peripheral axonal projections.
In Smad1 cKOWnt1 embryos, peripheral trigeminal sensory
axons initiated in the correct directions and with axonal lengths
similar to those of control embryos (Figure S4A). The axonal
projections to face, trunk, and limb buds also exhibited similar
length, fasciculation, and branching patterns (Figures S4B–
S4D). Thus, the initial axon growth did not appear to be affected
in the Smad1 cKO mice. Note that even though in vivo exposure
to NGF occurs much later in DRG neurons, E12.5 DRG neurons
are already capable of responding to NGF in vitro. Therefore,
whereas blocking BMP signaling in E12.5 DRG explants
attenuated axon growth stimulated by exogenous NGF, the
early phase of axon growth in vivo appeared normal in E12.5
Smad1 cKO mutants.CpSmad1C Directly Regulates Erk1/2 Transcription
in Embryonic Sensory Neurons
We next investigated the mechanism by which Smad1 is
involved in neurotrophin-dependent sensory axonal outgrowth.
Because Smad1 is a transcription factor, we searched for
transcriptional targets of Smad1 that may play a role in neurotro-
phin signaling. We took a candidate approach by analyzing
messenger RNA (mRNA) levels of neurotrophin effectors. After
they were normalized to Gapdh (a housekeeping gene), Erk1,
Erk2, and TrkA were significantly downregulated in DM-treated
E12.5 DRGs, whereas transcription of another Trk effector, Akt,
was not changed (Figure 4A). Transcripts of Rpl13a (another
housekeeping gene) remained unchanged, indicating that BMP
inhibition does not lead to global transcriptional repression.
A time-course study showed that mRNAs of Erk1 and Erk2
began to decline 6 hr after DM treatment and remained down-
regulated after 48 hr (Figure 4B). Consistent with the DM
treatment results, in freshly collected DRGs from WT or Smad1
cKONes embryos, both Erk1 and Erk2 were reduced in mutant
DRGs (Figure 4C). Conversely, BMP stimulation led to induction
of Erk1/2 in cultured E12.5 DRG neurons (Figure 4D).
We subsequently focused on Erk1/2 regulation. Western
blotting confirmed a marked decrease of Erk1/2 in DM-treated
E12.5 DRG neurons and a concordant depletion of phospho-
rylated Erk1/2 (pErk1/2; Figure 4E). Erk1/2 was similarly downre-
gulated after DM treatment in brain-derived neurotrophic factor
(BDNF)- and NT3-dependent DRG neurons (Figure 4F). In
contrast, inhibiting TGF-b or PKA did not alter Erk1/2 or pErk1/
2 levels (Figures 4G and S1B), in agreement with the above-
mentioned findings that axonal outgrowth was unaffected by
these two inhibitors. In addition, we confirmed a decrease of
Erk1/2 and pErk1/2 in E12.5 DRGs from both Smad1 cKONes
and Smad1 cKOWnt1 embryos as compared with controls by
western blotting (Figures 4H–4I), albeit to a smaller extent than
in cultured DM-treated DRG neurons. This may be explained
by in vivo compensatory mechanisms that maintain a tight
transcriptional regulation of Erk1/2. Also notable is that the
magnitude of reduction of Erk1/2 or pErk1/2 was smaller in
E12.5 DRGs from Smad1 cKONes than in those from Smad1
cKOWnt1 embryos, which may be related to an earlier Smad1
deletion in the latter.
To establish a direct link between pSmad1C and Erk1 and Erk2
transcription, we analyzed the Erk1 and Erk2 promoter regions,
and identified multiple conserved GC-rich Smad-binding ele-
ments (SBEs) within 1 kb upstream of the transcription start
site (TSS; Figures 5A and S5A; Morikawa et al., 2011). Chromatin
immunoprecipitation (ChIP) on freshly dissected E12.5 DRG
neurons showed preferential binding of pSmad1C to the SBE-
containing region of the Erk2 promoter as compared with the
internal coding or promoter regions that do not contain SBEs
(Figure 5B). pSmad1C occupancy on the SBE-containing Erk2
promoter is a direct result of BMP stimulation, as we observed
an 8-fold increase of pSmad1C binding in a ChIP assay per-
formed in BMP-treated Neuro-2A cells and a concomitant
3-fold increase in Erk2 expression (Figures 5C and 5D). We did
not detect any changes of pSmad1C binding in the internal
coding region of Erk2 or on the promoter of a housekeeping
gene, Gapdh (Figure 5C). Similar findings were obtained forell Reports 3, 1592–1606, May 30, 2013 ª2013 The Authors 1597
Figure 4. The BMP Pathway Is Involved in Regulating Erk1/2 Transcription
(A) qRT-PCR of mRNA extracts from dissociated E12.5 DRG neurons cultured for 48 hr with or without DM (1 mM). Data were normalized to Gapdh (n = 6).
(B) Time-course analysis of Erk1 and Erk2 transcripts by qRT-PCR from E12.5 dissociated DRG neurons cultured with DM (1 mM) for the indicated period as
compared with no DM treatment (at 0 hr; n = 6).
(C) qRT-PCR of mRNA extracts from DRGs of E12.5 Smad1 cKONes or control littermates.
(D) mRNA levels of Erk1/2 from dissociated DRG treated with or without BMP (10 ng/ml) for 24 hr.
(E–G) Western blots of protein extracts from dissociated E12.5 DRG neurons cultured for 48 hr in the specific neurotrophin-containing media (E and F) with or
without DM (1 mM), or (G) with SB431542 (SB, 5 mM), with antibodies against the indicated proteins (H3 as loading control).
(H and I) Western blots of protein extracts of DRGs from E12.5 Smad1 cKONes (H) or Smad1 cKOWnt1 (I) littermates with antibodies against the indicated proteins
show a decrease in Erk1/2 and pErk1/2 in both mutant DRGs (H3 and H4 as loading control). Asterisks in (H) denote the Erk2 band.
Error bars represent SEM. See also Figure S4.
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Figure 5. pSmad1C Regulates Erk1/2
Transcription
(A) Erk2 contains conserved SBEs in its promoter
region. Human, mouse, and rat Erk2 promoter
sequences were aligned and one GC-rich SBE is
highlighted in gray. The schematic representation
of the Erk2 gene shows the location of SBEs in
the Erk2 promoter. For clarity, only one SBE is
shown here. The locations of the qPCR primer sets
covering specific promoter or coding regions are
shown at the bottom.
(B) Relative enrichment of ChIP values. The
pSmad1/5/8C-immunoprecipitated DNA from
freshly dissected E12.5 DRGs was amplified by
qPCR using primer sets shown in (A) (n = 3).
(C) ChIP assays with antibody against pSmad1/
5/8C using Neuro-2A cells treated with BMP
(50 ng/ml) or DM (2 mM) for 1 hr before crosslinking
(n = 3). Gapdh is a housekeeping gene.
(D) qRT-PCR for Erk2 expression in Neuro-2A
cells treated with BMP4 (50ng/ml) or DM (2 mM).
(E) Schematic model of pSmad1C, activated
by BMP, drives Erk1/2 transcription, leading to
enhanced NGF responsiveness of developing
sensory axons.
Error bars represent SEM. See also Figure S5.Erk1 (Figures S5C–S5E). Collectively, our data support the notion
that BMP/pSmad1C plays a direct role in regulating Erk1 and
Erk2 transcription, thereby sensitizing developing axons to neu-
rotrophins (Figure 5E).
Neurotrophin Signaling Results in Linker
Phosphorylation of Smad1 in Developing Sensory
Neurons
So far, we have established that pSmad1C-mediated transcrip-
tional regulation of Erk1/2 serves to integrate BMP and neuro-
trophin signaling. To identify additional convergence points,
particularly in light of themultiple MAPK sites in the Smad1 linker
region, we investigated the functional roles of pSmad1L during
sensory axon development. To this end, we studied a mouse
mutant that harbors phosphorylation-resistant mutations in all
four MAPK phosphorylation sites (but not GSK phosphorylation
sites) in the Smad1 linker region. Smad1L/L mutant mice are
viable and exhibit subtle defects in gastric epithelial homeostasis
(Aubin et al., 2004), but their neural development has never been
studied.
We first examined whether the Smad1 linker region is phos-
phorylated in developing sensory neurons. Immunostaining
demonstrated a persistent presence of pSmad1L in the nuclei
of developing DRG neurons from E12.5 to P1, but its absence
in developing Schwann cells (Figures 6A and S6F–S6H). The
pSmad1L antibody was specific because its immunoreactivity
was absent in either Smad1L/L or Smad1 cKONes mutant DRGs
(Figures 6A and 6B).
To establish a direct link between neurotrophin stimulation
and linker phosphorylation of Smad1, we cultured dissociated
E12.5 DRG neurons in media with or without NGF for 24 hr, with
caspase inhibitor included to prevent cell death. Neurotrophin
stimulation by NGF, BDNF, or NT3 indeed led to a marked in-
crease in pSmad1L inWT, but notSmad1L/L, neurons (Figure 6C).CLinker Phosphorylation of Smad1 Functions to
Attenuate Neurotrophin/Erk Signaling
We next investigated the functional role of pSmad1L in sensory
neuron development. Previous studies in non-neuronal cell
cultures reported conflicting results with regard to whether
Smad1 linker phosphorylation antagonizes BMP activity by
tethering pSmad1C in the cytoplasm (Aubin et al., 2004;
Kretzschmar et al., 1997). We found that linker mutation did
not impact the nuclear accumulation of pSmad1C at baseline
or upon BMP stimulation in E12.5 DRG neurons (Figure 6D).
Additionally, pSmad1C stability was not altered, as the steady-
state levels of pSmad1C were comparable in Smad1L/L and
control E12.5 DRGs by western blotting or immunostaining
(Figures 6E and 6G).
We then considered the possibility that Smad1 requires phos-
phorylation at both the linker region and C terminus for optimal
transcriptional activity of pSmad1C, as shown previously in
non-neuronal cell lines (Alarco´n et al., 2009; Gao et al., 2009).
Since we had identified Erk1 and Erk2 as pSmad1C target genes,
we expected that Erk1/2 mRNA levels would serve as a readout
of pSmad1C transcriptional activity. We therefore compared
the mRNA levels of Erk1 or Erk2 in E12.5 Smad1L/L and control
DRGs, and found no significant difference (Figure 6F). In addi-
tion, when pSmad1C activation was blocked with DM, both
Erk1 and Erk2 were downregulated by a similar magnitude in
Smad1L/L and control DRG neurons (Figure S6A). Thus, linker
phosphorylation of Smad1 does not affect pSmad1C transcrip-
tional activity, at least for Erk1/2. Consistently, Erk1/2 protein
levels remained unaltered in Smad1L/L DRGs (Figure 6G).
Unexpectedly, we found that pErk1/2 was elevated in E12.5
Smad1L/L DRGs compared with controls (Figure 6G), suggesting
that linker phosphorylation of Smad1 may affect the balance be-
tween Erk1/2 and pErk1/2, favoring a decrease in pErk1/2.
Because Erk can activate linker phosphorylation of Smad1, weell Reports 3, 1592–1606, May 30, 2013 ª2013 The Authors 1599
Figure 6. pSmad1L Is Activated by Neurotrophins and Dampens Its Signaling Intensity
(A and B) Immunohistochemistry of pSmad1L in DRGs from P1 pups of the indicated genotypes and quantification.
(C) Immunocytochemistry of pSmad1L in dissociated E12.5 WT DRG neurons cultured for 24 hr with or without the indicated neurotrophin. Caspase inhibitor was
included in all conditions to prevent cell death. The percentage of nuclei that were pSmad1L+ was quantified from WT DRGs only, because no pSmad1L
immunosignals were detected in Smad1L/L DRGs.
(D) Immunocytochemistry of pSmad1/5/8C in dissociated E12.5 DRG neurons cultured with or without BMP (10 ng/ml) for 24 hr. The percentage of DRG neurons
with strong nuclear pSmad1C immunosignals remained similar in Smad1L/L and Smad1L/+ DRGs (n = 3). n.s., not statistically significant.
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hypothesize that Erk/pSmad1L may be part of a negative-feed-
back loop that dampens the signaling intensity of the neurotro-
phin/Erk signaling (Figure 6H). To evaluate this model in vivo,
we examined terminal axon branches in Smad1L/L newborn
pups. If pSmad1L functions as a brake for neurotrophin stimula-
tion, the lack of such a brake, as observed in Smad1L/L DRGs,
would lead to exaggerated growth of terminal branches. Indeed,
in the mystacial pads of newborn Smad1L/L pups, even though
the number of terminal axon branches at the upper dermis re-
mained the same, a significantly larger number of axonal
branches extended beyond the upper dermis and into the
epidermal layer, resulting in longer average axonal lengths in
the cutaneous axon network (Figures 7C and S7A). This change
was not due to alterations in the expression level of PGP9.5 or an
increased number of PGP9.5+ neurons, as cell differentiation and
survival were unaffected (Figures S6B–S6E).
The Smad1 linker mutation is present in both neurons and glial
cells, but the absence of pSmad1L in developing Schwann cells
suggests that the overgrowth of terminal axon branches is more
likely associated with the enhanced growth state of Smad1L/L
mutant DRG neurons, perhaps due to the elevated ratio of
pErk1/2 over Erk1/2. We thus conducted a neurite outgrowth
assay in DRG explant cultures. With stimulation of exogenous
NGF (12.5 ng/ml), axonal outgrowth appeared similar regardless
of the genotypes (Figure 7A). However, when the total Erk1/2
was reduced with a low dose of DM (1 mM) to ensure that
pErk1/2 would not reach saturating levels, Smad1L/L DRG neu-
rons grew longer axons as compared with controls (Figure 7A).
These results provide a direct link between the linker mutation
and the enhanced growth state of developing sensory neurons.
Together, our data suggest that pSmad1L is involved in reducing
pErk1/2 levels, leading to attenuated axonal outgrowth.
pSmad1L Induces Erk1/2-Specific Dusps to Modulate
the Intensity of Erk1/2 Signaling
We next sought to address the cause of elevated pErk1/2 in
Smad1L/L mutant DRGs. The level of Erk1/2 phosphorylation is
a result of balanced activities between Erk-specific kinases
and phosphatases. Because components of the NGF signaling
cascade, such as TrkA, Akt, and Erk, remained unchanged in
Smad1L/LDRGs (Figure 6F), we examined Erk-specific phospha-
tases. Dual-specificity (threonine/tyrosine) phosphatases
(Dusps) are a subclass of phosphatases that specifically de-
phosphorylate MAPKs (Jeffrey et al., 2007). Among the 16
mammalian Dusps that show catalytic activity for MAPK, we
examined the Dusps that have substrate preference for Erk1/2
over JNK or p38. The mRNA levels of Dusp2, Dusp4, and
Dusp6 were significantly decreased in E12.5 Smad1L/L DRGs,
whereas the mRNA levels of Dusp5 and Dusp9 remained the
same (Figure 7D). Dusp3 and Dusp8 do not act upon Erk1/2,
and their mRNA levels were not affected (Figure 7D). Consis-(E) pSmad1C levels were not affected in P1 DRGs from Smad1L/L as shown by im
(F) qRT-PCR for expression of components of the neurotrophin pathway from E1
(G)Western blot of protein extracts from E12.5 DRGs from a linker mutant or contr
(H) Schematic illustrating how pSmad1L is involved in regulating pErk levels.
Scale bars: 50 mm (A–C and E) and 100 mm (D). *p < 0.05, **p < 0.01, ***p < 0.00
Ctently, Dusp4 and Dusp6, but not Dusp3, were also down-
regulated in Smad1 cKONestin DRGs compared with controls
(Figure 7E). Taken together, our data suggest that pSmad1L is
involved in the regulation of Erk1/2-specific Dusp levels.
We subsequently focused on Dusp6 because it functions as a
negative-feedback regulator of FGF/Erk signaling during mouse
development (Li et al., 2007). We first investigated whether neu-
rotrophin/Erk signaling induces Dusp6. Neurotrophin stimulation
of E12.5 DRGs led to a 4-fold induction of Dusp6. Importantly,
the induction was abolished in Smad1L/L DRGs (Figure 7F).
Dusp6 induction was evident by increased immunoreactivity in
WT, but not Smad1L/L, DRG neurons treated with NGF (Fig-
ure 7B). Taken together, our data suggest that Dusp6 is specif-
ically regulated in embryonic DRGs by neurotrophin-activated
pSmad1L and acts as a brake to attenuate neurotrophin/Erk
signaling (Figure 7G).
DISCUSSION
By studying two Smad1 cKO and Smad1L/L mutants, we have
revealed in vivo roles of two phosphorylated forms of Smad1
during sensory axon development: pSmad1C mediates Erk1/2
transcription to sensitize neurotrophin response, and pSmad1L
regulates Dusp6 induction to dampen neurotrophin signaling
through a negative-feedback loop mechanism. BMP and neuro-
trophin pathways are thus tightly integrated into a signaling
network to ensure proper responses to the growth stimulation
from growth factors.
A Balanced Ratio of Erk1/2 and pErk1/2 in Developing
Sensory Neurons Ensures a Proper Response to
Neurotrophin Stimulation
Sensory neurons in DRGs are exposed to neurotrophins
throughout development that mediate their survival, differentia-
tion, and axonal outgrowth (White et al., 1996). Early axonal
outgrowth is NGF independent, whereas terminal arborization
is regulated by target-derived NGF. En route to target fields,
developing axons also encounter other members of the neuro-
trophin family, such as BDNF andNT3. Along the axon trajectory,
developing axons may encounter fluctuating concentrations of
neurotrophins. How a proper level of neurotrophin responsive-
ness is ensured is an important yet unanswered question.
Here, we demonstrate that in developing DRG neurons, tran-
scription of Erk1 and Erk2, two key neurotrophin effectors, is
regulated by Smad1. Furthermore, activity of Erk1/2 is also
modulated by Smad1 through Dusp-mediated dephosphoryla-
tion of Erk. Notably, the former process is controlled by
pSmad1C and the latter by pSmad1L. The pSmad1L/Dusp6-
based negative-feedback loop mechanism may prevent large
fluctuations of the signaling intensity of neurotrophin by main-
taining a balanced ratio of Erk1/2 and pErk1/2 (Figure 7G). Ofmunohistochemistry.
2.5 DRGs from Smad1+/+ and Smad1L/L embryos.
ol littermate shows that the levels of pErk1/2 were increased in Smad1L/LDRGs.
1. Error bars represent SEM. See also Figure S6.
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Figure 7. pSmad1L Mediates Dusp6 Expression
(A) Neurite outgrowth assay on E12.5 DRG explants. The axonal lengths of Smad1L/L neurons were compared with those of control DRGs at 24 hr in the presence
of 12.5 ng/ml of NGF with or without DM treatment (n = 4).
(B) Immunocytochemistry and quantification of dissociated E12.5 DRG neurons cultured with caspase inhibitor alone or with NGF for 48 hr showed that the
increased Dusp6 after NGF treatment was observed in WT but not Smad1L/L DRGs (n = 3).
(C) Immunostaining of mystacial pads from P1 pups for PGP9.5 (green) demonstrated exaggerated growth of terminal axons beyond the upper dermis and
into the epidermis (white arrows point to several examples) inSmad1L/L comparedwithSmad1+/+ pups. Dottedwhite lines depict the dermis/epidermis boundary.
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note, both BMP4 and BMP receptors are expressed in E12.5
DRGs (Figure S7B). Our working model thus reveals the molec-
ular basis of how growth stimulation from neurotrophins can
be constantly modulated and swiftly turned off once the target
innervation approaches completion.
Erk1/2 also play critical roles in developing Schwann cells
(Newbern et al., 2011); however, since the immunoreactivity of
pSmad1C or pSmad1L is not detectable in developing Schwann
cells, regulation of Erk1 and Erk2 in these cells may rely on
entirely different transcription factors. For a similar reason,
a neuronal cell-autonomous effect is more likely for the pheno-
types observed in Smad1 mutant mice. Two additional obser-
vations further favor a neuronal rather than a glial defect in
Smad1 mutant mice: First, the Smad1 cKONes and Smad1
cKOWnt-1 mutants have similar phenotypes. Because Nestin-
Cre leads to recombination more specifically in neurons in the
DRGs, it is more likely that the sensory neurons are the cellular
components that are responsible for the phenotypes. Second,
in cultured explants of DRGs from Smad1 cKONes mice, axon
outgrowth is affected. An indirect effect from glial cells remains
a possibility.
Besides the well-studied role of NGF in peripheral nervous
system development, other members of the neurotrophin
family (BDNF in particular) play a number of roles in the CNS,
ranging from axonal and dendritic growth to synaptogenesis,
learning, and memory (Aguado et al., 2003; Cheng et al.,
2011; Yamada et al., 2002). Whether a similar Smad1-based
regulatory mechanism functions in the CNS to maintain a
balanced ratio of Erk1/2 and pErk1/2 remains to be determined
in future studies.
pSmad1C-Mediated Erk1/2 Transcription Sensitizes
Sensory Neurons to Neurotrophins
This study extends previous findings regarding amodulatory role
of BMP in the functions of neurotrophin by revealing that
pSmad1C-mediated Erk1/2 transcription is the basis for this
collaboration in developing sensory neurons. Along with Erk1/
2, blocking of Smad1C activation results in a decrease in the
transcription of other neurotrophin signaling components, such
as TrkA, suggesting a broader role for Smad1 in regulating
neurotrophin signaling. The functional link between Smad1 and
Erk1/2 is highly significant given the prominent role of Erk1/2
in the growth and differentiation of a wide variety of cells, and
the observation that their aberrant regulation contributes to
neoplastic transformation (Roberts and Der, 2007).
Here, we establish that BMP/Smad1 signaling is specifically
required for NGF-mediated axon growth, but not for cell survival
or differentiation of developing sensory neurons. CGRP expres-
sion in sensory neurons is reportedly dependent on TrkA (SniderThe average number of axon branches per field of inspection, the percentage o
length in the terminal network of axons were quantified from five independent 20
(D and E) qRT-PCR of Dusp transcript levels in E12.5 DRGs from embryos of the
(F) qRT-PCR of Dusp6 and Dusp3 transcript levels in E12.5 DRGs from Smad1+/+
with or without NGF. Dusp6 was induced by NGF only in control DRGs.
(G) Working model. During DRG sensory neuron development, BMP activates pS
siveness, while neurotrophin activates pSmad1L to regulate Erk-specific Dusp, w
Scale bars: 50 mm (C) and 100 mm (A, B, D, and E). Error bars represent SEM. Se
Cand McMahon, 1998) and can be induced by BMP in cultured
DRGs in vitro (Ai et al., 1999). However, we detected no signifi-
cant change in the percentage or the total number of CGRP+
DRG neurons in Smad1 cKO pups, arguing against an indispens-
able role for Smad1 in mediating CGRP expression in DRG
neurons in vivo, although compensatory effects from Smad5
or Smad8 remain a possibility. Indeed, Smad1, Smad5, and
Smad8 are all expressed in the trigeminal sensory neurons
(Ji and Jaffrey, 2012).
The phenotype of stunted terminal axonal branches is milder
in Smad1 cKO pups than in Erk1/2 knockout mice (Newbern
et al., 2011), which may be attributed to a modest reduction of
Erk1/2 in Smad1 cKO DRGs as compared with the dramatic
reduction in cultured DM-treated DRG neurons. The difference
between the in vivo and in vitro results may be related to (1) a
compensatory increase in the transcriptional activity of other
Smads or additional transcriptional factors to maintain a tight
transcriptional regulation of Erk1/2 in vivo, and (2) the fact that
Smad1 deletion results in not only Erk1/2 reduction but also
compromised Dusp induction, leading to a smaller reduction in
pErk1/2 levels. It is also worth noting that although trigeminal
sensory neurons are derived from both neural crest progenitors
and epithelial placodal progenitors (Streit, 2011), Wnt1-Cre
affects only the former, which may explain the partial decrease
in terminal axon branches in the mutants.
A Negative-Feedback Loop of Neurotrophin/Erk
Signaling Relies on pSmad1L-Mediated Expression
of Erk-Specific Dusp
Once the sensory axons complete target innervation, growth
signals need to be effectively switched off to avoid overgrowth.
Previous studies have focused mostly on activation of the
neurotrophin-Ras-Raf-MEK-MAPK cascade, and paid little
attention to inactivation mechanisms. Our study uncovers a
pSmad1L/Dusp-based negative-feedback mechanism that en-
ables developing sensory neurons to attenuate neurotrophin/
Erk signaling intensity. Phosphatases are powerful negative
regulators. In fact, the enzymatic power of a phosphatase is
estimated to be 100–1,000 times greater than that of a kinase
(Reth, 2002), and computational analyses confirmed a domi-
nant role of Dusps over kinases with regard to the extent of
MAPK phosphorylation (Bhalla et al., 2002). Our results are in
agreement with the notion that Dusp is induced upon MAPK
activation to dampen mitogenic signaling (Patterson et al.,
2009). Moreover, a similar functional link between Smad1 and
Dusp has been identified in murine embryonic stem cells, which
sets appropriate Erk activity levels to maintain pluripotency
(Li et al., 2012). Different Dusps have distinct substrate speci-
ficities, subcellular localizations, and functions (Pattersonf cutaneous axons extending beyond the upper dermis, and the mean axonal
3 images for each pup and averaged over four littermate pairs.
indicated genotypes (n = 3).
or Smad1L/L embryos cultured for 48 hr in caspase-inhibitor-containing media
mad1C to induce Erk1/2 transcription, which enhances neurotrophin respon-
hich dampens the NGF/Erk signaling intensity.
e also Figure S7.
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et al., 2009), and the present study suggests that Dusp6 is
involved in attenuating axonal outgrowth in developing sensory
neurons. Future studies will uncover the roles of each individual
Dusp during neural development.
Distinct Roles of pSmad1C and pSmad1L during Sensory
Axon Development
In this study, we have assigned distinct in vivo roles to the two
phosphorylated forms of Smad1. Thus, differential posttransla-
tional modifications of the same transcription factor can lead
to distinct transcription programs. This has been demonstrated
for other transcription factors, such as Nkx2-1 (Silberschmidt
et al., 2011), Sap-1a (Janknecht and Hunter, 1997), and NF-kB
(Anrather et al., 2005). In the case of NF-kB, differential phos-
phorylation of p65, one of the subunits of NF-kB, results in
distinct gene-expression profiles.
We demonstrate that pSmad1C binds to SBE on Erk1 and Erk2
promoters upon BMP stimulation. It remains to be determined
whether Dusp6 induction is regulated directly by pSmad1L,
and if so, whether pSmad1L and pSmad1C bind to the same
or different SBEs, and collaborate with the same or distinct co-
factors to mediate transcription. Indeed, precedent exists for
specific recruitment of a transcriptional coactivator, yes-associ-
ated protein (YAP), to the phosphorylated linker region of Smad1
(Alarco´n et al., 2009). YES acts downstream of the Hippo
pathway to control organ size (Zhao et al., 2008). Our findings
suggest that Smad1 plays versatile roles in regulating different
sets of genes through differential phosphorylation, thereby
enabling neurons to respond to combinations of instructive
cues in a context-specific manner.
Conclusions
We have identified collaborative signaling events of BMP and
NGF pathways during sensory axon development. Through
differential phosphorylation, Smad1 potentiates neurotrophin
signaling by pSmad1C-dependent transcription of Erk1/2, and
then dampens its signaling intensity by pSmad1L-mediated
Dusp expression. The concerted integration of the BMP and
neurotrophin pathways forms a tightly regulated signaling
network that is of key importance for sensory axon development.
EXPERIMENTAL PROCEDURES
Generation of Mice
Smad1flox/flox mice (Huang et al., 2002) were used to generate a heterozygous
germline deletion of Smad1 (Smad1+/). Smad1fl/ mice were then mated to
Nestin-Cre mice (The Jackson Laboratory; Tronche et al., 1999) to generate
Smad fl/;Nestin-Cre conditional mutant mice, or toWnt1-Cre mice (Danielian
et al., 1998) to generate Smad fl/;Wnt1-Cremice. TheSmad1L/Lmutant (Aubin
et al., 2004) and Rosa26-EGFPSTOP reporter line (Srinivas et al., 2001) were
obtained from The Jackson Laboratory. At least five littermate pairs were
used for each phenotype studied.
DRG Cultures and Neurite Outgrowth Assay
DRGs from E12.5 embryos were dissected for explant cultures or low-density
(50,000 cells/cm2) dissociated cultures in Neurobasal media supplemented
with B27 (GIBCO) and NGF (12.5 ng/ml). The lengths of at least 20 axons
from each explant, or >100 dissociated neurons, were measured and aver-
aged for each experiment. A minimum of three replicates were performed
for each condition.1604 Cell Reports 3, 1592–1606, May 30, 2013 ª2013 The AuthorsChIP
The ChIP-IT enzymatic kit (Active Motif) was used per the manufacturer’s
instructions. Briefly, crosslinked chromatin from Neuro-2A cells or freshly
dissected E12.5 DRGs was enzymatically digested to yield 150–200 bp frag-
ments and incubated overnight with magnetic beads plus 5 mg of pSmad1/
5/8C (Cell Signaling; see Table S1) antibody or water at 4C. This was followed
by crosslinking reversal, proteinase K digestion, DNA extraction (PCR purifica-
tion kit; QIAGEN), and quantitative PCR (qPCR) with the primer sets listed in
Table S2. The specific binding of pSmad1/5/8C to promoters was calculated
by subtracting the value of the no-antibody control and then normalized to
the diluted input (1:10). The relative enrichment was then calculated as
arbitrary units relative to the ChIP value at the coding region.
Statistical Analysis
Prism GraphPad software was used for Student’s t test, one-way ANOVA, or
two-way ANOVA, followed by Bonferroni’s post hoc test for multiple compar-
isons. Data are presented as mean ± SEM (*p < 0.05; **p < 0.01; ***p < 0.001;
****p < 0.0001).
For further details about the materials and methods used in this work, see
Extended Experimental Procedures.SUPPLEMENTAL INFORMATION
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